Evidence map›Paper›PMID 19774383›Full record

ArticleRheumatology international2009

TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet's Disease.

Mortaza Bonyadi, Zohreh Jahanafrooz, Mohsen Esmaeili, Susan Kolahi, Alireza Khabazi, Ali Asghar Ebrahimi, Mehrzad Hajialilo, Saeed Dastgiri

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. The role of miRNAs in Behçet's disease.Frontiers in immunology · 2023
    Review
  4. A Darwinian View of Behçet's Disease.Rheumatology and immunology research · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Expression of TNF-α, APRIL and BCMA in Behcet's disease.Journal of immunology research · 2014
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mortaza BonyadiMedical-Molecular Genetics, Center of Excellence for Biodiversity, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. jabbarpour@tabrizu.ac.ir
Zohreh Jahanafrooz
Mohsen Esmaeili
Susan Kolahi
Alireza Khabazi
Ali Asghar Ebrahimi
Mehrzad Hajialilo
Saeed Dastgiri
Tabriz University of Medical Sciences · IRUniversity of Tabriz · IRImam Reza Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic factors that predispose individuals to Behcet's disease (BD) are considered to play an important role in the development of the disease. The serum level of tumor necrosis factor (TNF) is elevated in patients with BD, and a dramatic response to anti-TNF-alpha antibody treatment further supports the role of TNF in BD. We investigated the distribution of TNF-alpha promoter -1031T/C and -308G/A polymorphisms in 53 BD patients of Iranian Azeri Turks and 79 matched healthy controls, via the PCR-RFLP technique. The frequency of the TNF-alpha -1031C allele was significantly higher in Behcet's patients than in healthy controls (p < 0.0001, OR = 3.08; 95% CI = 1.73-5.47), whereas the frequency of the TNF-alpha -308A allele was similar in the two compared groups. The frequency of CG haplotype was significantly higher (p < 0.0001, OR = 3.42; 95% CI = 1.89-6.18), and that of the TA haplotype was significantly lower in BD patients than in healthy controls. These results suggest that TNF-alpha is a susceptibility gene for BD in patients from Iranian Azeri Turk ethnic group.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticAdultBehcet SyndromeFemaleGene FrequencyHaplotypesHumansIranMalePolymorphism, Single NucleotidePromoter Regions, GeneticTumor Necrosis Factor-alphaTumor Necrosis Factor-alpha

Identifiers

PMID19774383
OpenAlexW2120816253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.